Plasma IgM, IgA, and IgG antibody levels against the S RBD of the Wuhan strain, as well as the Alpha, Delta, and Omicron variants, were determined at three different time points, and the results were compared between COVID-19 patients and CoronaVac-vaccinated individuals (Fig. 1; Table 2). This evidence concerns the gene CD79A and COVID-19.